Table 1.
Demographic and Clinical Characteristics of the Sample
| First-Episode Psychosis (N = 61) |
|||
| Mean | SD | Range | |
| Age at hospitalization (y) | 23.4 | 3.7 | 17.5–30.8 |
| Education | 11.8 | 2.6 | 7–18 |
| PANSS positive total | 12.1 | 5.2 | 7–28 |
| PANSS negative total | 13.5 | 4.8 | 7–30 |
| DUP (d) | 53.2 | 94.2 | 2–591 |
| Calgary Depression Scale (total) | 2.0 | 2.9 | 0–11 |
| Hamilton Anxiety Scale (total) | 3.6 | 3.6 | 0–14 |
| BCIS | |||
| Self-reflectiveness | 13.3 | 4.0 | 3–22 |
| Self-certainty | 8.3 | 3.2 | 2–18 |
| Composite index | 5.0 | 5.7 | −11–19 |
| SUMD | |||
| Awareness of mental disorder | 2.4 | 1.4 | 1–5 |
| Awareness of response to medication | 2.1 | 1.4 | 1–5 |
| Awareness of need for treatment | 2.5 | 1.5 | 1–5 |
| Medication adherencea | 3.1 | 1.4 | 0–4 |
| Antipsychotic (dose [mg])b | 235.9 | 277.7 | 0–1250 |
| N | % | ||
| Gender (M:F) | 43:18 | 70:30 | |
| Diagnostic category | |||
| Schizophrenia | 37 | 60.7 | |
| Schizoaffective disorder | 9 | 14.8 | |
| Schizophreniform disorder | 1 | 1.6 | |
| Psychosis not otherwise specified | 7 | 11.5 | |
| Delusional disorder | 1 | 1.6 | |
| Bipolar disorder | 5 | 8.2 | |
| Undetermined | 1 | 1.6 | |
Note: PANSS, Positive and Negative Syndrome Scale; DUP, duration of untreated psychosis; BCIS, Beck Cognitive Insight Scale; SUMD, Scale to assess Unawareness of Mental Disorder.
a
Medication adherence: 0 (never taken) to 4 (always taken).
b
Antipsychotic medication reported as chlorpromazine equivalent dosage in milligrams. Six patients were unmedicated.